Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

UnitedHealth Group (UNH) Q2 2024 Earnings Call Transcript
UnitedHealth Group (UNH) Q2 2024 Earnings Call Transcript

Image source: The Motley Fool.

UnitedHealth Group (NYSE: UNH)Q2 2024 Earnings CallJul 16, 2024, 8:45 a.m. ET

Operator

Continue reading

Source Fool.com

How Much Will Medtronic Pay Out in Dividends This Year?: https://g.foolcdn.com/editorial/images/783445/medical-professional-holding-dollar-sign-paperweight.jpg
How Much Will Medtronic Pay Out in Dividends This Year?

Medtronic (NYSE: MDT), a beast of a medical-device company, has caught the eye of more than a few income investors. It has enacted dividend raises at least once annually for a hard-to-beat 47 years

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever: https://g.foolcdn.com/editorial/images/783101/healthcare-chemist.jpg
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever

Healthcare is an evergreen industry, meaning it will always be around. People will always need care, and naturally, they will strive for newer and better medicines and technologies to provide it

3 High-Yield Dividend Stocks to Buy in the 2nd Half of 2024 and Hold at Least a Decade: https://g.foolcdn.com/editorial/images/783355/investor-sofa-laptop-getty.jpg
3 High-Yield Dividend Stocks to Buy in the 2nd Half of 2024 and Hold at Least a Decade

The market's been on a bull run, but most of the gains have been confined to a handful of tech stocks at the top. There are still plenty of high-yield dividend stocks that haven't gained as much

2 Healthcare Stocks to Buy Hand Over Fist This Month: https://g.foolcdn.com/editorial/images/782612/doctor-and-patient-in-a-hospital-room.jpg
2 Healthcare Stocks to Buy Hand Over Fist This Month

Healthcare never sleeps. There is always demand for medical services, regardless of the state of the economy. Companies that offer these necessary goods and are innovative enough to keep up with the

How Much Will UnitedHealth Group Pay Out in Dividends This Year?: https://g.foolcdn.com/editorial/images/782855/unitedhealth-unh-stock-dividend-income-dividends.jpg
How Much Will UnitedHealth Group Pay Out in Dividends This Year?

UnitedHealth Group (NYSE: UNH) stock hasn't performed well this year so far, but there's a consolation prize for long-term investors. Every three months, UnitedHealth Group distributes a cash payout

History Says These Could Be 3 of the Best Healthcare Stocks to Own in the Second Half of 2024: https://g.foolcdn.com/editorial/images/782718/stock-traders-looking-at-a-chart.jpg
History Says These Could Be 3 of the Best Healthcare Stocks to Own in the Second Half of 2024

The S&P 500 has remained red hot, achieving gains of nearly 15% through the first six months of 2024. Healthcare stocks have performed well, but not nearly to the same extent -- the Healthcare

EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures H1 2024: Earnings above prior year
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures H1 2024: Earnings above prior year
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures H1 2024: Earnings above prior year
EQS-News: Gerresheimer remains on track in 1st half year 2024
EQS-News: Gerresheimer remains on track in 1st half year 2024
EQS-News: Gerresheimer remains on track in 1st half year 2024
How Great Is It to Have Customers That Absolutely Love You and Plan to Never Leave You?
How Great Is It to Have Customers That Absolutely Love You and Plan to Never Leave You?

ResMed has had the market on sleep apnea cornered for a while, but new weight loss drugs might be creeping in. In this podcast, we look at what could change based on recent studies and some other

EQS-News: Sartorius AG: After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office – Supervisory Board expresses great regret
EQS-News: Sartorius AG: After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office – Supervisory Board expresses great regret
EQS-News: Sartorius AG: After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office – Supervisory Board expresses great regret
EQS-Adhoc: SARTORIUS AG: After more than 20 years as CEO,  Joachim Kreuzburg will not pursue another term in office
EQS-Adhoc: SARTORIUS AG: After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office
EQS-Adhoc: SARTORIUS AG: After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office
Agilent Names Bret DiMarco Chief Legal Officer
Agilent Names Bret DiMarco Chief Legal Officer


Agilent Technologies, Inc. (NYSE: A) today announced Bret DiMarco has been named to lead the company’s global legal organization as senior vice president and chief legal officer, as well as serving

Agilent’s ESG Report Highlights Expansion of Solutions to Help Labs Manage Their Environmental Footprint
Agilent’s ESG Report Highlights Expansion of Solutions to Help Labs Manage Their Environmental Footprint


Agilent Technologies Inc. (NYSE: A) today released the company’s annual ESG report, showcasing a comprehensive and growing set of sustainable solutions that enable hundreds of thousands of labs

Is UnitedHealth Group Stock a Millionaire Maker?
Is UnitedHealth Group Stock a Millionaire Maker?

Making a million dollars from a single stock sounds like it could be an unrealistic goal. But if you pick a good growth stock, which also pays a dividend, and hold on to it for the long haul, it's

EQS-Adhoc: Carl Zeiss Meditec AG: Revenue and EBIT forecast for fiscal year 2023/24 reduced amid slower than expected recovery of equipment business
EQS-Adhoc: Carl Zeiss Meditec AG: Revenue and EBIT forecast for fiscal year 2023/24 reduced amid slower than expected recovery of equipment business
EQS-Adhoc: Carl Zeiss Meditec AG: Revenue and EBIT forecast for fiscal year 2023/24 reduced amid slower than expected recovery of equipment business
Got $200? 2 Healthcare Stocks to Buy and Hold Forever.
Got $200? 2 Healthcare Stocks to Buy and Hold Forever.

Few industries are more essential than healthcare. That makes it an excellent place to look for stocks that can perform well over extended periods since the basic services they offer are unlikely to

3 Reasons to Buy Rivian Now
3 Reasons to Buy Rivian Now

There are plenty of reasons to be pessimistic about the electric vehicle (EV) industry now, but that could also make it a perfect time to buy in while stock prices are depressed. To be fair, not

University of Louisville Study Outlines Humana’s Economic and Community Impact on Kentucky
University of Louisville Study Outlines Humana’s Economic and Community Impact on Kentucky


The University of Louisville’s College of Business recently released the results of a study that evaluated Humana’s economic and community impact on Kentucky.


This press release features

Eli Lilly Hits an All-Time High: Is the Soaring Pharma Stock Still a Buy?
Eli Lilly Hits an All-Time High: Is the Soaring Pharma Stock Still a Buy?

Johnson & Johnson reigned as the largest healthcare company in the world for years. UnitedHealth Group also took a turn at the top. However, the title now belongs to Eli Lilly (NYSE: LLY) -- and it

What Is the Dividend Payout for UnitedHealth Group Stock?
What Is the Dividend Payout for UnitedHealth Group Stock?

Healthcare giants sometimes pay decent dividend distributions, and UnitedHealth Group (NYSE: UNH) certainly falls into that category. In the wake of difficult circumstances, however, investors might

U.S. Rep. Thomas Kean Jr. Just Bought Illumina Stock and Sold Nike Stock. Should You Do the Same?
U.S. Rep. Thomas Kean Jr. Just Bought Illumina Stock and Sold Nike Stock. Should You Do the Same?

On April 19, U.S. Rep. Thomas Kean Jr., R-N.J., bought shares of Illumina (NASDAQ: ILMN) and sold shares of Nike (NYSE: NKE), according to a May 31 filing. Although it's unclear exactly how many

Medtronic Raised Its Dividend for a 47th Straight Year, But Here's Why It Isn't a Great Dividend Growth Stock
Medtronic Raised Its Dividend for a 47th Straight Year, But Here's Why It Isn't a Great Dividend Growth Stock

Dividend growth stocks can make for excellent long-term investments. Their ongoing rate increases allow investors to generate more in dividend income than if they were to just invest in a stale

Dexcom G7 Now Connects Directly to Apple Watch in the U.S.
Dexcom G7 Now Connects Directly to Apple Watch in the U.S.


DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the Dexcom G7 Continuous Glucose Monitoring (CGM) System now